This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | |||
bacteria:t3e:xoph [2025/02/24 16:34] – [The Type III Effector XopH from //Xanthomonas//] rkoebnik | bacteria:t3e:xoph [2025/07/04 23:34] (current) – jfpothier | ||
---|---|---|---|
Line 2: | Line 2: | ||
Author: [[https:// | Author: [[https:// | ||
- | Internal reviewer: [[https:// | + | Internal reviewer: [[https:// |
Class: XopH\\ | Class: XopH\\ | ||
Line 18: | Line 18: | ||
The XopH effector, also known as AvrBs1.1 (White //et al//., 2009), was first reported in 1988 (Ronald and Staskawicz 1988) and discovered due to its virulent activity (Gurenn //et al//., 2006). Later, this effector began to be identified based on the coregulation with the TTS system (Gurlebeck //et al//., 2006), most recently began to be identified by a combination of biochemical approaches, including a new NMR-based method to discriminate inositol polyphosphate enantiomers (Blüher //et al//., 2017). | The XopH effector, also known as AvrBs1.1 (White //et al//., 2009), was first reported in 1988 (Ronald and Staskawicz 1988) and discovered due to its virulent activity (Gurenn //et al//., 2006). Later, this effector began to be identified based on the coregulation with the TTS system (Gurlebeck //et al//., 2006), most recently began to be identified by a combination of biochemical approaches, including a new NMR-based method to discriminate inositol polyphosphate enantiomers (Blüher //et al//., 2017). | ||
+ | |||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
The effector XopH, inhibited flg22-induced callose deposition //in planta// (Popov //et al//., 2016), dephosphorylates myo- inositol-hexakisphosphate (phytate, InsP6) to produce InsP5[1-OH], | The effector XopH, inhibited flg22-induced callose deposition //in planta// (Popov //et al//., 2016), dephosphorylates myo- inositol-hexakisphosphate (phytate, InsP6) to produce InsP5[1-OH], | ||
+ | |||
=== Regulation === | === Regulation === | ||
Line 28: | Line 30: | ||
This effector can inhibit flg22- but not ABA-inducible reporter gene activation in protoplasts act as PTI inhibitors in planta and contribute to development of disease symptoms like chlorosis (Popov //et al//., 2016). XopH liberates phosphate from the plant tissue to improve the nutritional status of the pathogen what causes the plant show obvious symptoms of phosphorus deficiency (Blüher //et al//., 2017). Transgenic //Nicotiana benthamiana// | This effector can inhibit flg22- but not ABA-inducible reporter gene activation in protoplasts act as PTI inhibitors in planta and contribute to development of disease symptoms like chlorosis (Popov //et al//., 2016). XopH liberates phosphate from the plant tissue to improve the nutritional status of the pathogen what causes the plant show obvious symptoms of phosphorus deficiency (Blüher //et al//., 2017). Transgenic //Nicotiana benthamiana// | ||
+ | |||
=== Localization === | === Localization === | ||
The effector XopH is localized in the nucleus and in the cytoplasm of the plant cell (Popov //et al//., 2016; Blüher //et al//., 2017). | The effector XopH is localized in the nucleus and in the cytoplasm of the plant cell (Popov //et al//., 2016; Blüher //et al//., 2017). | ||
+ | |||
=== Enzymatic function === | === Enzymatic function === | ||
XopH is a T3E with phytate-degrading activity, //in vitro// and //in planta// (Blüher //et al//., 2017). | XopH is a T3E with phytate-degrading activity, //in vitro// and //in planta// (Blüher //et al//., 2017). | ||
+ | |||
=== Interaction partners === | === Interaction partners === | ||
Line 43: | Line 48: | ||
Yes (//e.g. Xanthomonas campestris pv. campestris// | Yes (//e.g. Xanthomonas campestris pv. campestris// | ||
+ | |||
=== In other plant pathogens/ | === In other plant pathogens/ | ||